Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Jay M. Sosenko"'
Autor:
theTrialNet Study Group, Maria J. Redondo, Jay S. Skyler, Kevan C. Herold, Carmella Evans-Molina, Mark A. Atkinson, Laura M. Jacobsen, Brandon M. Nathan, Heba M. Ismail, Emily K. Sims, David Cuthbertson, Jay M. Sosenko
Objective Metabolic zones were developed to characterize heterogeneity of individuals with islet autoantibodies. Research Design and Methods Baseline 2-hour oral glucose tolerance test (OGTT) data from 6,620 TrialNet Pathway to Prevention Study (TNPT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8fab9e2ee6992384f085a1149a69f0
https://doi.org/10.2337/figshare.22190029
https://doi.org/10.2337/figshare.22190029
Publikováno v:
Clin Diabetes
Autor:
Laura M. Jacobsen, Brandon M. Nathan, Maria J. Redondo, Susan Geyer, Laura E. Bocchino, Jerry P. Palmer, Heba M. Ismail, Jay S. Skyler, Emily K. Sims, Jay M. Sosenko
Publikováno v:
Diabetes Care
OBJECTIVE We assessed whether Index60, a composite measure of fasting C-peptide, 60-min C-peptide, and 60-min glucose, could improve the metabolic staging of type 1 diabetes for progression to clinical disease (stage 3) among autoantibody-positive (A
Autor:
Emily K. Sims, David Cuthbertson, Jamie L. Felton, Heba M. Ismail, Brandon M. Nathan, Laura M. Jacobsen, Emily Paprocki, Alberto Pugliese, Jerry Palmer, Mark Atkinson, Carmella Evans-Molina, Jay S. Skyler, Maria J. Redondo, Kevan C. Herold, Jay M. Sosenko
Publikováno v:
Diabetes care. 45(12)
OBJECTIVE We studied longitudinal differences between progressors and nonprogressors to type 1 diabetes with similar and substantial baseline risk. RESEARCH DESIGN AND METHODS Changes in 2-h oral glucose tolerance test indices were used to examine va
Autor:
Mustafa, Tosur, Mario A, Cleves, Jay M, Sosenko, Ingrid, Libman, David A, Baidal, Ashok, Balasubramanyam, Maria J, Redondo, Fiona, Williams
Publikováno v:
J Clin Endocrinol Metab
The Journal of Clinical Endocrinology and Metabolism
The Journal of Clinical Endocrinology and Metabolism
Objective We set forth to compare ethnicities for metabolic and immunological characteristics at the clinical diagnosis of type 1 diabetes (T1D) and assess the effect of ethnicity on beta-cell functional loss within 3 years after clinical diagnosis.
Autor:
Jerry P. Palmer, Lisa E. Rafkin, Susan Geyer, Desmond A. Schatz, Alberto Pugliese, Della Matheson, Jay S. Skyler, Michael J. Haller, Jay M. Sosenko, Mario A Cleves, Kevan C. Herold
Publikováno v:
Diabetes
We assessed whether oral insulin slowed metabolic decline after 1 year of treatment in individuals at high risk for type 1 diabetes. Two oral insulin trials that did not show efficacy overall and had type 1 diabetes as the primary end point were anal
Autor:
Jay M. Sosenko, Mario A Cleves, Ingrid Libman, Dorothy J. Becker, Jerry P. Palmer, Heba M. Ismail, Maria J. Redondo, Kevan C. Herold, Mark A. Atkinson
Publikováno v:
Diabetes Obes Metab
We examined whether the timing of the C-peptide response during an oral glucose tolerance test (OGTT) in relatives of patients with type 1 diabetes (T1D) is predictive of disease onset. We examined baseline 2-h OGTTs from 670 relatives participating
Autor:
Jay M. Sosenko, Kara Mizokami-Stout, Andrew J.M. Boulton, Rodica Pop-Busui, Catherine C. Cowie, Sarah Stark Casagrande
Publikováno v:
J Clin Endocrinol Metab
Context Evidence suggests that heart rate (HR) is a prognostic factor for cardiovascular disease (CVD), for which persons with diabetes are at increased risk. Objective The objective of this article is to determine the association between HR and glyc
Autor:
Karen Dimentstein, Della Matheson, Stephen W. Ponder, James M. Shultz, Zelde Espinel, Carlos Alberto Leyva Jordán, Jay M. Sosenko
Publikováno v:
Disaster Medicine and Public Health Preparedness. 14:150-154
The 2017 Atlantic hurricane season was especially memorable for 3 major hurricanes—Harvey, Irma, and Maria—that devastated population centers across Texas, Florida, and Puerto Rico, respectively. Each storm had unique hazard properties that posed
Autor:
Ingrid Libman, Maria J. Redondo, Susan Geyer, Jay M. Sosenko, Mark A. Atkinson, Dorothy J. Becker, Mustafa Tosur, Jennifer J.F. McVean
Publikováno v:
J Clin Endocrinol Metab
Context Multiple islet autoantibody positivity usually precedes clinical (stage 3) type 1 diabetes (T1D). Objective To test the hypothesis that individuals who develop stage 3 T1D with only a single autoantibody have unique metabolic differences. Des